Charles Schwab tests spot trading in Q2, CME expands capacity for clone derivatives, CORZ will clear the treasury

Mars Finance News, according to BBX data, based on yesterday’s market official announcements and corporate regulatory filings, the latest developments in compliance infrastructure and mining-company treasury strategies among global brokerage giants are as follows:

Charles Schwab confirms spot trading schedule: In a letter to shareholders this Monday, Rick Wurster, President and CEO of The Charles Schwab Corporation (NYSE: $SCHW), formally confirmed that Charles Schwab will launch spot trading services for Bitcoin and Ethereum in the first half of 2026. The plan will roll out in the second quarter (Q2) with a limited test release under restrictions (Limited Rollout), followed by a full expansion to its vast client base.

CME derivatives compliance expansion: CME Group Inc. (NASDAQ: $CME) announced that, given that in March this year its crypto derivatives average daily notional trading volume hit a historical record of $8.0 billion, the company has decided to further step up its crypto strategy and will officially list Bitcoin futures contracts—standard and micro versions—on May 4, for Avalanche (AVAX) and Sui (SUI).

Core Scientific plans to fully clear its Bitcoin reserves: In the latest released 10-K annual and quarterly regulatory filings, Core Scientific, Inc. (NASDAQ: $CORZ) provided extremely clear guidance to Wall Street: during 2026, the company expects to “substantially monetize all” of its held Bitcoin reserves to enhance liquidity and fund planned capital expenditures. This means the company will fundamentally shift to becoming a spot seller, liquidating its digital treasury to purchase the hardware needed for an AI transformation.